Company intelligence / Profile preview

Costa

Santa Ana, San José, Costa Rica

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Costapharm is a licensed pharmaceutical importer and distributor specializing in the Central American health market. The company focuses on providing access to sophisticated and innovative medicines, including biologicals, oncologicals, monoclonal antibodies, and orphan drugs. Costapharm operates by leveraging global pharmaceutical partnerships to supply both private healthcare providers and government tender systems. Headquartered in Costa Rica, the firm emphasizes ethical support for high-quality, affordable treatments to address unaddressed health issues in the region.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Monoclonal antibodyBiologicSmall moleculePlasma proteins
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Costa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Costa.

Explore the full profile